Lucene search

K
nvd[email protected]NVD:CVE-2020-10627
HistoryDec 01, 2021 - 4:15 p.m.

CVE-2020-10627

2021-12-0116:15:07
CWE-284
web.nvd.nist.gov

4.8 Medium

CVSS2

Attack Vector

ADJACENT_NETWORK

Attack Complexity

LOW

Authentication

NONE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

NONE

AV:A/AC:L/Au:N/C:P/I:P/A:N

8.1 High

CVSS3

Attack Vector

ADJACENT

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

NONE

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

0.001 Low

EPSS

Percentile

26.7%

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Affected configurations

NVD
Node
insuletomnipod_insulin_management_system_firmwareMatch-
AND
insuletomnipod_insulin_management_systemMatch19191
OR
insuletomnipod_insulin_management_systemMatch40160

4.8 Medium

CVSS2

Attack Vector

ADJACENT_NETWORK

Attack Complexity

LOW

Authentication

NONE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

NONE

AV:A/AC:L/Au:N/C:P/I:P/A:N

8.1 High

CVSS3

Attack Vector

ADJACENT

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

NONE

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

0.001 Low

EPSS

Percentile

26.7%

Related for NVD:CVE-2020-10627